[go: up one dir, main page]

GB1318291A - Carboxamide derivatives and fungicidal compositions containing them - Google Patents

Carboxamide derivatives and fungicidal compositions containing them

Info

Publication number
GB1318291A
GB1318291A GB1318291DA GB1318291A GB 1318291 A GB1318291 A GB 1318291A GB 1318291D A GB1318291D A GB 1318291DA GB 1318291 A GB1318291 A GB 1318291A
Authority
GB
United Kingdom
Prior art keywords
carboxamide derivatives
ring
april
group
compositions containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Shell Internationale Research Maatschappij BV
Original Assignee
Shell Internationale Research Maatschappij BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shell Internationale Research Maatschappij BV filed Critical Shell Internationale Research Maatschappij BV
Publication of GB1318291A publication Critical patent/GB1318291A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/30—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/14—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/44—Acylated amino or imino radicals
    • C07D277/46—Acylated amino or imino radicals by carboxylic acids, or sulfur or nitrogen analogues thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/54—Nitrogen and either oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
    • C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
    • C07D317/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

1318291 Carboxamide derivatives SHELL INTERNATIONAL RESEARCH MAATSCHAPPIJ BV 19 April 1971 [15 April 1970 25 June 1970] 17956/70 and 30896/70 Heading C2C Carboxamide derivatives of the general formula in which R represents an optionally substituted aromatic heterocyclic group containing at least one nitrogen atom, or a methylenedioxyphenyl group; A represents an alkyl group and B represents a hydrogen atom, or A and B, together with the two carbon atoms to which they are linked, jointly represent an optionally alkyl substituted benzene, furan or thiazole ring, a dihydro-oxathiin ring or dioxide thereof or, when R is other than a methylenedioxyphenyl group, additionally represent a dihydropyran ring, are prepared by reacting the corresponding acid halide with the appropriate primary amine. The compounds have fungicidal properties.
GB1318291D 1970-04-15 1970-04-15 Carboxamide derivatives and fungicidal compositions containing them Expired GB1318291A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB1795670 1970-04-15
GB3089670 1970-06-25

Publications (1)

Publication Number Publication Date
GB1318291A true GB1318291A (en) 1973-05-23

Family

ID=26253026

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1318291D Expired GB1318291A (en) 1970-04-15 1970-04-15 Carboxamide derivatives and fungicidal compositions containing them

Country Status (7)

Country Link
JP (1) JPS547857B1 (en)
CH (1) CH552339A (en)
DE (1) DE2117807A1 (en)
ES (1) ES390121A1 (en)
FR (1) FR2089546A5 (en)
GB (1) GB1318291A (en)
NL (1) NL7104858A (en)

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005049018A1 (en) * 2003-11-14 2005-06-02 Vertex Pharmaceuticals Incorporated Thiazoles and oxazoles useful as modulators of atp-binding cassette transporters
EP1797878A2 (en) * 2000-06-21 2007-06-20 F. Hoffmann-La Roche AG Benzothiazole derivatives
US7851636B2 (en) 2004-01-06 2010-12-14 Novo Nordisk A/S Heteroaryl-ureas and their use as glucokinase activators
US7884210B2 (en) 2005-07-14 2011-02-08 Novo Nordisk A/S Ureido-thiazole glucokinase activators
US7897628B2 (en) 2002-06-27 2011-03-01 Novo Nordisk A/S Aryl carbonyl derivatives as therapeutic agents
US7999114B2 (en) 2005-07-08 2011-08-16 Novo Nordisk A/S Dicycloalkylcarbamoyl ureas as glucokinase activators
US8138185B2 (en) 2007-01-09 2012-03-20 Novo Nordisk A/S Urea glucokinase activators
US8318778B2 (en) 2007-01-11 2012-11-27 Novo Nordisk A/S Urea glucokinase activators
US11833136B2 (en) 2018-06-12 2023-12-05 Vtv Therapeutics Llc Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101124245B1 (en) 2002-06-27 2012-07-02 노보 노르디스크 에이/에스 Aryl carbonyl derivatives as therapeutic agents
FR2926297B1 (en) 2008-01-10 2013-03-08 Centre Nat Rech Scient INHIBITORY CHEMICAL MOLECULES IN THE SPLICE MECHANISM FOR TREATING DISEASES RESULTING FROM SPLICE ANOMALIES.
EP2505198A1 (en) 2011-04-01 2012-10-03 Société Splicos Compounds for use as therapeutic agents affecting p53 expression and/or activity

Cited By (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1797878A3 (en) * 2000-06-21 2010-01-20 F. Hoffmann-La Roche AG Benzothiazole derivatives
EP1797878A2 (en) * 2000-06-21 2007-06-20 F. Hoffmann-La Roche AG Benzothiazole derivatives
US8063081B2 (en) * 2002-06-27 2011-11-22 Novo Nordisk A/S Aryl carbonyl derivatives as therapeutic agents
US7897628B2 (en) 2002-06-27 2011-03-01 Novo Nordisk A/S Aryl carbonyl derivatives as therapeutic agents
EP2140865A1 (en) * 2003-11-14 2010-01-06 Vertex Pharmaceuticals Incorporated Thiazoles and oxazoles useful as modulators of atp-binding cassette transporters
US7846951B2 (en) 2003-11-14 2010-12-07 Vertex Pharmaceuticals Incorporated Thiazoles and oxazoles useful as modulators of ATP-binding cassette transporters
US8232302B2 (en) 2003-11-14 2012-07-31 Vertex Pharmaceuticals Incorporated Thiazoles and oxazoles useful as modulators of ATP-binding cassette transporters
WO2005049018A1 (en) * 2003-11-14 2005-06-02 Vertex Pharmaceuticals Incorporated Thiazoles and oxazoles useful as modulators of atp-binding cassette transporters
US7407976B2 (en) 2003-11-14 2008-08-05 Vertex Pharmaceuticals Incorporated Thiazoles and oxazoles useful as modulators of ATP-Binding Cassette transporters
US7851636B2 (en) 2004-01-06 2010-12-14 Novo Nordisk A/S Heteroaryl-ureas and their use as glucokinase activators
US7872139B2 (en) 2004-01-06 2011-01-18 Novo Nordisk A/S Heteroaryl-ureas and their use as glucokinase activators
USRE45183E1 (en) 2004-01-06 2014-10-07 Novo Nordisk A/S Heteroaryl-ureas and their use as glucokinase activators
US8263634B2 (en) 2004-01-06 2012-09-11 Novo Nordisk A/S Heteroaryl-ureas and their use as glucokinase activators
US7999114B2 (en) 2005-07-08 2011-08-16 Novo Nordisk A/S Dicycloalkylcarbamoyl ureas as glucokinase activators
US8586614B2 (en) 2005-07-14 2013-11-19 Novo Nordisk A/S Urea glucokinase activators
US7884210B2 (en) 2005-07-14 2011-02-08 Novo Nordisk A/S Ureido-thiazole glucokinase activators
US8138185B2 (en) 2007-01-09 2012-03-20 Novo Nordisk A/S Urea glucokinase activators
US8318778B2 (en) 2007-01-11 2012-11-27 Novo Nordisk A/S Urea glucokinase activators
US8362049B2 (en) 2007-01-11 2013-01-29 Novo Nordisk A/S Urea glucokinase activators
US11833136B2 (en) 2018-06-12 2023-12-05 Vtv Therapeutics Llc Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs
US11974989B2 (en) 2018-06-12 2024-05-07 Vtv Therapeutics Llc Therapeutic uses of glucokinase activators in combination with insulin or insulin analogs

Also Published As

Publication number Publication date
JPS547857B1 (en) 1979-04-10
ES390121A1 (en) 1974-05-01
CH552339A (en) 1974-08-15
DE2117807A1 (en) 1971-10-28
NL7104858A (en) 1971-10-19
FR2089546A5 (en) 1972-01-07

Similar Documents

Publication Publication Date Title
GB1325192A (en) Phloroglucinol derivatives
GB1318291A (en) Carboxamide derivatives and fungicidal compositions containing them
GB1149139A (en) New herbicidal compounds and compositions
GB1382782A (en) Alkylarylketones processes for their preparation and compositions incorporating them
ES459412A1 (en) Heterocyclic compound
GB1369248A (en) Amides the preparation thereof and their use in pharmacjeutical compositions
GB1529330A (en) Acid addition salts of 3-(4'-piperidyl)-indole derivative
IE42945L (en) 1-acylaminomethyl-1, 2, 3, 4-tetrahydroisoquinolines
GB1386150A (en) 6-acylaminophenyl-4,5-dihydropyridazones
ES433148A1 (en) Pyrazole derivatives
ES447081A1 (en) Pyrazol-5-ones
ES446132A1 (en) A procedure for the preparation of new derivatives of 2-alkyl (bottom) -2 or 3-cefem-4-carboxylic acid. (Machine-translation by Google Translate, not legally binding)
GB1043158A (en) Improvements in or relating to piperidylalkidene-5h-dibenzo(a,d)cycloheptenes
GB1514709A (en) Fungicidal thioamides
GB1423346A (en) Colour formers
GB1335403A (en) Pharmaceutical compositions containing benzofuran derivatives
GB1221389A (en) 2,4-dicyano-6-nitrobenzene derivatives
GB1289658A (en)
IE35148L (en) Sulphamyl benzoic acid piperazides
GB1396042A (en) Derivatives of 1-2-thienyl-2-amino-ethanol and their preparation
GB1352464A (en) N-alkyl-alpha-3,5-substituted phenoxy-alkyl amides and their use as herbicides
GB1527941A (en) 1-(3-phenylpropyl)-4-(beta-alkoxyacryloyl)piperazine derivatives
GB1420728A (en) Cephalosporins
ES390275A1 (en) A procedure for the preparation of 1,2-dialquil (lower) pirrolydines. (Machine-translation by Google Translate, not legally binding)
GB1150614A (en) Pyrylium Compounds

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee